BioSig Technologies, Inc. STEX Net Operating Loss Carryforwards
Net Operating Loss Carryforwards at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOtherLossCarryforwards.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s net operating loss carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s net operating loss carryforwards?
- BioSig Technologies, Inc. (STEX) reported net operating loss carryforwards of $52.99M in Q4 2025.
- How has BioSig Technologies, Inc.'s net operating loss carryforwards changed year-over-year?
- BioSig Technologies, Inc.'s net operating loss carryforwards increased by 16.9% year-over-year, from $45.32M to $52.99M.
- What is the long-term trend for BioSig Technologies, Inc.'s net operating loss carryforwards?
- Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s net operating loss carryforwards has grown at a -11.0% compound annual growth rate (CAGR), from $95M to $52.99M.
- What does net operating loss carryforwards mean?
- These are tax assets representing losses that can be used to reduce taxable income in future periods. They provide a potential future tax shield, improving cash flow by lowering future tax payments. Investors monitor these to estimate the duration and magnitude of potential tax savings.